Lisata Therapeutics Inc. Revenue 2010–2025
Lisata Therapeutics Inc. annual/quarterly revenue history and growth rate from 2010 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lisata Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0.
- Lisata Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 70000.
- Lisata Therapeutics Inc. annual revenue for 2025 was 170000, a 83.00% decrease from 2024.
- Lisata Therapeutics Inc. annual revenue for 2024 was 1.0 M.
- Lisata Therapeutics Inc. annual revenue for 2023 was 0.
- Lisata Therapeutics Inc. annual revenue for 2022 was 0.
Lisata Therapeutics Inc. (LSTA) — Frequently Asked Questions
Lisata Therapeutics Inc. (LSTA) is a publicly traded US company. It has a market capitalization of $30M. In fiscal 2025 it reported revenue of $170,000 and net income of -$17M. Explore LSTA's stock price, financial statements, earnings history, margins and key ratios below.
What is Lisata Therapeutics Inc.'s market cap?
Lisata Therapeutics Inc. (LSTA) has a market capitalization of $30M.
What is the LSTA stock price?
LSTA trades at $3.46 (-4.02% on the day).
How much revenue does Lisata Therapeutics Inc. make?
Lisata Therapeutics Inc. reported revenue of $170,000 in fiscal 2025.
Is LSTA profitable?
In fiscal 2025, Lisata Therapeutics Inc. reported net income of -$17M.